MichaelAndrewMorseMD

Clinical Trials

• Flt3L in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 1998 Jun 01

  Completed

  Phase 1

• Biological Therapy in Stage I, Stage II, or Stage III Surgically Resected Pancreatic Cancer Start of enrollment: 1998 Jun 01

  Terminated

  Phase 1

• Biological Therapy in Treating Patients With Advanced Cancer Start of enrollment: 2000 Feb 01

  Completed

  Not Applicable

• Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer Start of enrollment: 2005 Feb 01

  Completed

  Phase 2

• Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer Start of enrollment: 2005 Sep 01

  Completed

  Phase 1

• A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal Cancer Start of enrollment: 2007 Mar 01

  Completed

  Phase 1

• Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer Start of enrollment: 2006 Oct 01

  Completed

  Phase 2

• CMV pp65 Specific T Cell Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation for Malignant Disease Start of enrollment: 2005 Aug 01

  Terminated

  Phase 1

• A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Transplantation Start of enrollment: 2007 Jun 01

  Terminated

  Phase 1

• Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer Start of enrollment: 2009 Jul 01

  Completed

  Phase 1, Phase 2

• Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer Start of enrollment: 2011 Jun 01

  Withdrawn

  Phase 2

• PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy Start of enrollment: 2011 Aug 01

  Completed

• A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901 Start of enrollment: 2012 Feb 01

  Completed

  Phase 1

• HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma Start of enrollment: 2013 May 01

  Terminated

  Phase 4

• A Study of Niclosamide in Patients With Resectable Colon Cancer Start of enrollment: 2017 Nov 07

  Terminated

  Phase 1

• ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement Start of enrollment: 2019 Jun 10

  Recruiting

  Not Applicable

  Roles: Principal Investigator, Contact

• Join now to see all